Haemagglutination Induced by Bordetella pertussis Filamentous Haemagglutinin Adhesin (FHA) Is Inhibited by Antibodies Produced Against FHA430–873 Fragment Expressed in Lactobacillus casei
Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella pertussis related to the adhesion and spread of the bacteria through the respiratory tract. Three distinct domains have been characterized in mature FHA, and among them, the FHA442–863 fragment was suggested to be responsible for the heparin-binding activity. In this study, we cloned the gene encoding the HEP fragment (FHA430–873) in a Lactobacillus casei–inducible expression vector based on the lactose operon. The recombinant bacteria, transformed with the resulting construct (L. casei-HEP), were able to express the heterologous protein depending on the sugar added to the culture. Subcutaneous inoculation of L. casei-HEP in Balb/C mice, using the cholera toxin B subunit as adjuvant, induced systemic anti-HEP antibodies that were able to inhibit in vitro erythrocyte haemagglutination induced by FHA. This is the first example of a B. pertussis antigen produced in lactic acid bacteria and opens new perspectives for alternative vaccine strategies against whooping cough.
KeywordsPertussis Pertussis Vaccine Bordetella Pertussis Pool Seron Acellular Vaccine
This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Fundação Butantan and CNPq .
- 2.Arêas APM, Oliveira MLS, Miyaji EN, Leite LCC, Dias WO, Aires K, et al. (2004) Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: Ability of CTB-PsaA to induce humoral immune response in mice. Biochem Bioph Res Comm 321:192–196CrossRefGoogle Scholar
- 8.Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H (1997) Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 29:1569–1577CrossRefGoogle Scholar
- 9.Oliveira MLS, Arêas APM, Campos IB, Monedero V, Perez-Martínez G, Miyaji EN, et al. (2006) Induction of systemic and mucosal immune response and decrease of Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing the Pneumococcal Surface Antigen A (PsaA). Microbes Infect 8:1016–1024PubMedCrossRefGoogle Scholar
- 10.Posno M, Leer RJ, van Luijk N, van Giezen MJF, Heuvelmans PTHM, Lokman BC, et al. (1991) Incompatibility of lactobacillus vectors with replicons derived from small cryptic lactobacillus plasmids and segregational instability of the introduced vectors. Appl Environ Microbiol 57:1822–1828PubMedGoogle Scholar